The investigational vaccine known as mRNA-1273 protected mice from infection with SARS-CoV-2, the virus that causes COVID-19, according to research published today in Nature. Scientists at the National Institute of Allergy and Infectious Diseases (NIAID) and the biotechnology company Moderna, based in Cambridge, Massachusetts, along with collaborators from the University of North Carolina at Chapel Hill, Vanderbilt University Medical Center in Nashville, and the University of Texas at Austin conducted the preclinical research.
- When — not what — obese mice ate reduced breast cancer risk
- Impact of patient-reported symptom information on lumbar spine MRI Interpretation
- Finding a way to stop chemotherapy from damaging the heart
- Governments need to set clear rules for vaccinating health care workers against COVID-19
- In ED patients with chest and abdominal pain, care delivered by physicians and APPs is si